HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$2.79
Day range
$2.62 - $2.88
Year range
$0.61 - $14.09
Market cap
424.30M USD
Avg Volume
2.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 54.04M | -15.33% |
Net income | -52.73M | 10.17% |
Net profit margin | — | — |
Earnings per share | -0.33 | 10.81% |
EBITDA | -54.02M | 15.14% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.59M | -41.45% |
Total assets | 223.82M | -44.66% |
Total liabilities | 40.95M | 76.38% |
Total equity | 182.88M | — |
Shares outstanding | 161.95M | — |
Price to book | 2.47 | — |
Return on assets | -56.22% | — |
Return on capital | -62.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -52.73M | 10.17% |
Cash from operations | -52.40M | 6.68% |
Cash from investing | 30.40M | 43.01% |
Cash from financing | 18.46M | 595.44% |
Net change in cash | -3.55M | 88.99% |
Free cash flow | -32.86M | 6.57% |
About
Founded
2019
Headquarters
Website
Employees
96
